Alerts will be sent to your verified email
Verify Email
EMMESSA
|
Emmessar Biotech&Nut
|
Colinz Laboratories
|
Beryl Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.99 % | 4.71 % | 5.44 % |
|
5yr average Equity Multiplier
|
1.23 | 1.29 | 2.12 |
|
5yr Average Asset Turnover Ratio
|
0.25 | 0.64 | 1.19 |
|
5yr Avg Net Profit Margin
|
77.44 % | 5.84 % | 1.13 % |
|
Price to Book
|
1.5 | 1.11 | 1.06 |
|
P/E
|
36.09 | 22.26 | 791.97 |
|
5yr Avg Cash Conversion Cycle
|
63.13 Days | -11.59 Days | -589.78 Days |
|
Inventory Days
|
54.75 Days | 56.66 Days | 36.09 Days |
|
Days Receivable
|
11.98 Days | 42.5 Days | 112.55 Days |
|
Days Payable
|
169.78 Days | 89.1 Days | 964.25 Days |
|
5yr Average Interest Coverage Ratio
|
820.35 | 11.55 | 1.91 |
|
5yr Avg ROCE
|
17.27 % | 6.71 % | 7.2 % |
|
5yr Avg Operating Profit Margin
|
-130.11 % | 7.54 % | 6.72 % |
|
5 yr average Debt to Equity
|
0.0 | 0.07 | 0.59 |
|
5yr CAGR Net Profit
|
-26.08 % | 18.95 % | 19.3 % |
|
5yr Average Return on Assets
|
8.75 % | 3.68 % | 1.98 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
59.53 % | 66.0 % | 26.38 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.0 % | 0.0 | 1.46 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Emmessar Biotech&Nut
|
Colinz Laboratories
|
Beryl Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|